ArticleNon-coding RNA research2025

PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapy.

Andrei Gurau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.